Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 733,600 | 623,600 | 967,000 | 1,458,500 | 894,200 |
| Marketable Securities | 963,000 | 1,018,400 | 1,012,100 | 560,100 | 1,090,900 |
| Receivables | 1,998,300 | 2,083,100 | 1,968,400 | 1,665,000 | 1,641,500 |
| Inventories | 1,348,900 | 1,467,400 | 1,407,800 | 1,264,900 | 1,267,600 |
| Other current assets | 1,093,200 | 789,600 | 469,400 | 839,900 | 531,600 |
| TOTAL | $6,137,000 | $5,982,100 | $5,824,700 | $5,788,400 | $5,425,800 |
| Non-Current Assets | |||||
| PPE Net | 5,502,000 | 5,712,800 | 5,440,700 | 4,992,900 | N/A |
| Investments And Advances | 581,900 | 673,500 | 739,600 | 724,300 | 609,900 |
| Other Non-Current Assets | 2,628,600 | 2,700,100 | 2,520,400 | 1,512,600 | 1,423,900 |
| TOTAL | $8,712,500 | $9,086,400 | $8,700,700 | $7,229,800 | $2,033,800 |
| Total Assets | $12,821,100 | $12,945,400 | $12,515,300 | $11,098,500 | $10,401,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 1,300 | 0 | 0 |
| Accounts payable and accrued liabilities | 636,000 | 715,100 | 573,200 | 524,900 | 432,900 |
| Accrued Expenses | 409,500 | 397,800 | 348,700 | 419,000 | 364,900 |
| Other current liabilities | 1,019,700 | 1,208,000 | 1,035,000 | 930,900 | 899,100 |
| TOTAL | $5,799,400 | $6,102,500 | $5,777,300 | $4,825,900 | $4,139,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 358,200 | 611,200 | 609,900 | 604,200 | 586,300 |
| Other Non-Current Liabilities | 1,132,600 | 1,148,200 | 1,133,000 | 1,132,800 | 1,264,800 |
| TOTAL | $1,740,500 | $2,013,700 | $2,041,200 | $1,948,700 | $2,108,600 |
| Total Liabilities | $7,539,900 | $8,116,200 | $7,818,500 | $6,774,600 | $6,247,600 |
| Shareholders' Equity | |||||
| Common Shares | 34,200 | 34,100 | 34,100 | 34,000 | 34,000 |
| Retained earnings | 6,613,600 | 6,189,400 | 6,201,400 | 5,944,500 | 5,758,500 |
| Other shareholders' equity | -756,800 | -558,300 | -612,600 | -553,000 | -505,500 |
| TOTAL | $5,281,200 | $4,829,200 | $4,696,800 | $4,323,900 | $4,153,900 |
| Total Liabilities And Equity | $12,821,100 | $12,945,400 | $12,515,300 | $11,098,500 | $10,401,500 |